Richard BA - MeiraGTx Holdings COO CFO

MGTX Stock  USD 7.70  0.07  0.90%   

Insider

Richard BA is COO CFO of MeiraGTx Holdings PLC
Age 51
Address 450 East 29th Street, New York, NY, United States, 10016
Phone646 860 7985
Webhttps://meiragtx.com

MeiraGTx Holdings Management Efficiency

The company has return on total asset (ROA) of (0.3441) % which means that it has lost $0.3441 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4348) %, meaning that it created substantial loss on money invested by shareholders. MeiraGTx Holdings' management efficiency ratios could be used to measure how well MeiraGTx Holdings manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.58 in 2025. Return On Capital Employed is likely to drop to -0.83 in 2025. At this time, MeiraGTx Holdings' Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to rise to about 19.7 M in 2025, whereas Total Assets are likely to drop slightly above 252.7 M in 2025.
MeiraGTx Holdings PLC currently holds 4.05 M in liabilities with Debt to Equity (D/E) ratio of 0.16, which may suggest the company is not taking enough advantage from borrowing. MeiraGTx Holdings PLC has a current ratio of 1.52, which is within standard range for the sector. Note, when we think about MeiraGTx Holdings' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Jasbir SeehraKeros Therapeutics
69
James CPAEton Pharmaceuticals
53
BCh BMKronos Bio
40
Pr KatusUniqure NV
N/A
Chandra LovejoyErasca Inc
53
Gregory FlesherEledon Pharmaceuticals
54
Lei SunConnect Biopharma Holdings
61
Matthew KapustaUniqure NV
52
Stephanie YaoKronos Bio
N/A
Ricardo DolmetschUniqure NV
55
Robert BazemoreNuvation Bio
53
Badreddin EdrisEdgewise Therapeutics
37
Paul StoneIdeaya Biosciences
60
Siew MSAcumen Pharmaceuticals
N/A
Matthew MDIdeaya Biosciences
N/A
MS MBAGeneration Bio Co
47
Nik ChetwynErasca Inc
N/A
Christopher MScKeros Therapeutics
51
Gaurav MDRocket Pharmaceuticals
49
Erin BrennanSolid Biosciences LLC
51
Phillip SamayoaGeneration Bio Co
37
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York. MeiraGTx Holdings operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 333 people. MeiraGTx Holdings PLC (MGTX) is traded on NASDAQ Exchange in USA. It is located in 450 East 29th Street, New York, NY, United States, 10016 and employs 375 people. MeiraGTx Holdings is listed under Biotechnology category by Fama And French industry classification.

Management Performance

MeiraGTx Holdings PLC Leadership Team

Elected by the shareholders, the MeiraGTx Holdings' board of directors comprises two types of representatives: MeiraGTx Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MeiraGTx. The board's role is to monitor MeiraGTx Holdings' management team and ensure that shareholders' interests are well served. MeiraGTx Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MeiraGTx Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
Alexandria Forbes, President CEO, Director
Robert MD, Chief Officer
Tim Randall, Senior Controls
Christine Sheehy, Senior Integration
David Rubinstein, Senior Development
Richard BA, COO CFO
Joel Brooks, VP Fin
Alastair Leighton, Senior Chain
Stuart Naylor, Chief Development Officer
Robert JD, General Secretary
Michel MD, Head Ophthalmology

MeiraGTx Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MeiraGTx Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for MeiraGTx Stock Analysis

When running MeiraGTx Holdings' price analysis, check to measure MeiraGTx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MeiraGTx Holdings is operating at the current time. Most of MeiraGTx Holdings' value examination focuses on studying past and present price action to predict the probability of MeiraGTx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MeiraGTx Holdings' price. Additionally, you may evaluate how the addition of MeiraGTx Holdings to your portfolios can decrease your overall portfolio volatility.